Hello from me.
The eyes of much of the pharmaceutical world will be focused on Milan, with the city hosting the annual CPhI Worldwide. As I hope you will see from reading this issue of Pharma, the pressure on companies to develop and produce drugs that are fit for purpose and cost effective is growing ever greater.
On the one hand there is the ever-present question of patent control, who owns the drug and how long should that control last. How this 'game' pans out could affect us all. On the other there are concerns about how the industry can remain profitable: with job losses at Amgen and other big pharma/ biotech companies the question of profitability rests heavily on company boards, many with nervous shareholders looking warily over their shoulder.
I hope to see you at CPhI, Hall 16, B10 and, of course, at the European Outsourcing Awards dinner at the Le Meridien Gallia.
|Printer friendly Cite/link Email Feedback|
|Article Type:||Brief article|
|Date:||Sep 1, 2007|
|Previous Article:||All change, please! It's all change in the pharmaceutical industry.|
|Next Article:||Quo vadis, Novartis? It's kind of ironic that Novartis, a company known for its ethical stance and for helping the poor in developing countries...|